ALL OTHER THERAPEUTIC PRODUCTS

Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006. In the meantime, thank you for your patience.

Amifostine		For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.
Dexrazoxane		For reducing the incidence and severity of cardiomyopathy associated with doxorubicin administration in women with metastatic breast cancer
Ethanol		For therapeutic neurolysis of nerves or ganglia for the relief of intractable chronic pain in such conditions as inoperable cancer and trigeminal neuralgia (tic douloureux), in patients for whom neurosurgical procedures are contraindicated.
Glutathione
L-Methionine
Naloxone		Naloxone is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol.
Physostigmine		For the treatment of Glaucoma
Rasburicase		For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)